X
Please Wait
Applying Filters...
01 Adapalene (1)
02 Aminophylline (1)
03 Apalutamide (1)
04 Apixaban (1)
05 Apremilast (1)
06 Azathioprine (1)
07 Bambuterol Hydrochloride (1)
08 Benazepril Hydrochloride (1)
09 Bicalutamide (1)
10 Budesonide (1)
11 Bupropion Hydrochloride (1)
12 Caffeine (1)
13 Canagliflozin (1)
14 Ciclesonide (1)
15 Cinacalcet (1)
16 Cyclophosphamide (1)
17 Dapagliflozin (1)
18 Deferasirox (1)
19 Deferiprone (1)
20 Desonide (1)
21 Diflunisal (1)
22 Duloxetine (1)
23 Edoxaban Tosilate (1)
24 Elagolix (1)
25 Empagliflozin (1)
26 Enalapril (1)
27 Enzalutamide (1)
28 Fluticasone Furoate (1)
29 Fluticasone Propionate (1)
30 Formoterol Fumarate (1)
31 Ibrutinib (1)
32 Ifosfamide (1)
33 Ipratropium Bromide (1)
34 Levalbuterol Hydrochloride (1)
35 Loteprednol Etabonate (1)
36 Mercaptopurine (1)
37 Mesna (1)
38 Mirabegron (1)
39 Mometasone Furoate (1)
40 Montelukast Sodium (1)
41 Nilotinib (1)
42 Olaparib (1)
43 Olmesartan (1)
44 Olopatadine Hydrochloride (1)
45 Osimertinib (1)
46 Palbociclib (1)
47 Pazopanib (1)
48 Perindopril Arginine (1)
49 Perindopril Erbumine (1)
50 Phenylephrine Hydrochloride (1)
51 Quetiapine Fumarate (1)
52 Quinapril (1)
53 Ramipril (1)
54 Ranolazine (1)
55 Ribociclib (1)
56 Rivaroxaban (1)
57 Ruxolitinib (1)
58 Salbutamol Sulphate (1)
59 Salmeterol Xinafoate (1)
60 Sitagliptin Hydrochloride (1)
61 Sitagliptin Phosphate (1)
62 Theophyline (1)
63 Ticagrelor (1)
64 Tofacitinib Citrate (1)
65 Venetoclax (1)
66 Venlafaxine Hydrochloride (1)
67 Vortioxetine Hydrobromide (1)
68 etophylline (1)
01 Aarti Pharmalabs (68)
01 India (68)
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Buenos Aires 2023
Not Confirmed
Contact SupplierNote: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Buenos Aires 2023
Not Confirmed
Contact SupplierNote: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Buenos Aires 2023
Not Confirmed
Contact SupplierNote: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Buenos Aires 2023
Not Confirmed
Contact SupplierNote: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Buenos Aires 2023
Not Confirmed
Contact SupplierNote: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Buenos Aires 2023
Not Confirmed
Contact SupplierNote: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Buenos Aires 2023
Not Confirmed
Contact SupplierNote: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Buenos Aires 2023
Not Confirmed
Contact SupplierNote: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Buenos Aires 2023
Not Confirmed
Contact SupplierNote: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Buenos Aires 2023
Not Confirmed
Contact Supplier
Market Place
KEY PRODUCTS
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
